Unlike apelin or spexin, METRNLs receptor has not yet been definitively identified, placing it among ligands whose translational development is constrained by incomplete mechanistic understanding
Mounjaro takes this approach further by activating two hormone pathways instead of one
As researchers continue to explore the compound's full therapeutic capabilities, the list of its potential applications continues to grow
Early- to mid-stage trials in people with obesity (with and without type 2 diabetes) have reported substantial average weight reductions over 48 weeks at higher doses, alongside improvements in measures like waist circumference, blood lipids and liver fat in those with metabolic fatty liver disease
The page leans into patient education and clinical context and the details behind retatrutide
In others, it may not provide the benefits you are hoping for